CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Integrative Medicine

Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial. 📎

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (Probiotics for standard triple Helicobacter pylori eradication - a randomized, double-blind, placebo-controlled trial..pdf)Probiotics for standard triple Helicobacter pylori eradication - a randomized, double-blind, placebo-controlled trial..pdf[Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.]331 kB
facebook Share on Facebook
Abstract Title:

Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.

Abstract Source:

Medicine (Baltimore). 2015 May ;94(17):e685. PMID: 25929897

Abstract Author(s):

Goran Hauser, Nermin Salkic, Karina Vukelic, Alenka JajacKnez, Davor Stimac

Article Affiliation:

Goran Hauser

Abstract:

The primary objective in the study is determination of efficacy of probiotic preparation as a supportive therapy in eradication of Helicobacter pylori.The study was multicenter, prospective, randomized, placebo controlled, and double-blind. The subjects first filled out a specially designed questionnaire to assess the severity of the 10 symptoms, which can be related to eradication therapy to be monitored during the trial. Each subject then received 28 capsules of probiotic preparation or matching placebo capsules, which they were supposed to take over the following 14 days, twice a day, at least 2 hours prior to or after the antibiotic therapy administration.A total of 804 patients were enrolled in the trial, of which 650 (80.85%) were included in the analysis. The results show a significantly larger share of cured subjects in the probiotic arm versus the placebo arm (87.38% vs 72.55%; P < 0.001). Additionally, presence and intensity of epigastric pain, bloating, flatulence, taste disturbance, loss of appetite, nausea, vomiting, heartburn, rash, and diarrhea were monitored over the study period. At 15 days postinclusion, probiotic treatment was found superior to placebo in 7 of 10mentioned symptoms. Average intensity for symptoms potentially related to antibiotic therapy was significantly higher in the placebo group, 0.76 vs 0.55 (P < 0.001).Adding probiotics to the standard triple therapy for H pylori eradication significantly contributes to treatment efficacy and distinctly decreases the adverse effects of therapy and the symptoms of the underlying disease.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.